The Journal of Medical Microbiology, Vol 41, Issue 5 319-323, Copyright © 1994 by Society for General Microbiology

JOURNAL ARTICLE

Toxin production by Clostridium difficile in a defined medium with limited amino acids

K. Yamakawa, S. Kamiya, X. Q. Meng, T. Karasawa and S. Nakamura
Department of Bacteriology, School of Medicine, Kanazawa University, Ishikawa, Japan.

Basal defined medium (BDM) containing vitamins, minerals and seven amino acids--(/L) tryptophan 0.1 g, methionine 0.2 g, valine 0.3 g, isoleucine 0.3 g, proline 0.3 g, leucine 0.4 g and cysteine 0.5 g--which appeared to be essential for good growth of Clostridium difficile was prepared. Addition of glycine 0.2 g/L and threonine 0.4 g/L to BDM produced better growth of strain VPI 10463, and this defined medium was designated minimum amino acid-defined medium (MADM). Production of toxins A and B by strain VPI 10463 in 6 x MADM containing (/L) tryptophan 0.6 g, methionine 1.2 g, valine 1.8 g, isoleucine 1.8 g, proline 1.8 g, leucine 2.4 g, cysteine 0.5 g, glycine 0.2 g and threonine 0.4 g, was much greater than in MADM. Toxin production by 20 C. difficile strains was examined in two defined media--6 x MADM and complete amino acid-defined medium (CADM) containing 18 amino acids--and one complex medium, modified brain heart infusion medium (m-BHI). Simultaneous production of toxins A and B by all test strains was demonstrated in m-BHI and the two defined media. It was also shown that 6 x MADM was generally better than CADM and as effective as m-BHI for stimulating toxin production by 13 strains. This defined medium would be useful for studies on the physiology, metabolism and pathogenicity of C. difficile.

This article has been cited by other articles:

				S. Jackson, M. Calos, A. Myers, and W. T. Self Analysis of Proline Reduction in the Nosocomial Pathogen Clostridium difficile J. Bacteriol., December 15, 2006; 188(24): 8487 - 8495. [Abstract] [Full Text] [PDF]

				D. E. Voth and J. D. Ballard Clostridium difficile Toxins: Mechanism of Action and Role in Disease Clin. Microbiol. Rev., April 1, 2005; 18(2): 247 - 263. [Abstract] [Full Text] [PDF]

				S. Karlsson, B. Dupuy, K. Mukherjee, E. Norin, L. G. Burman, and T. Akerlund Expression of Clostridium difficile Toxins A and B and Their Sigma Factor TcdD Is Controlled by Temperature Infect. Immun., April 1, 2003; 71(4): 1784 - 1793. [Abstract] [Full Text]

				N. Mani, D. Lyras, L. Barroso, P. Howarth, T. Wilkins, J. I. Rood, A. L. Sonenshein, and B. Dupuy Environmental Response and Autoregulation of Clostridium difficile TxeR, a Sigma Factor for Toxin Gene Expression J. Bacteriol., November 1, 2002; 184(21): 5971 - 5978. [Abstract] [Full Text] [PDF]

				K. Mukherjee, S. Karlsson, L. G. Burman, and T. Akerlund Proteins released during high toxin production in Clostridium difficile Microbiology, July 1, 2002; 148(7): 2245 - 2253. [Abstract] [Full Text] [PDF]

				T. MAEGAWA, T. KARASAWA, T. OHTA, X. WANG, H. KATO, H. HAYASHI, and S. NAKAMURA Linkage between toxin production and purine biosynthesis in Clostridium difficile J. Med. Microbiol., January 1, 2002; 51(1): 34 - 41. [Abstract] [Full Text] [PDF]

				S. Karlsson, A. Lindberg, E. Norin, L. G. Burman, and T. Akerlund Toxins, Butyric Acid, and Other Short-Chain Fatty Acids Are Coordinately Expressed and Down-Regulated by Cysteine in Clostridium difficile Infect. Immun., October 1, 2000; 68(10): 5881 - 5888. [Abstract] [Full Text] [PDF]

				N. Mani and B. Dupuy Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor PNAS, May 8, 2001; 98(10): 5844 - 5849. [Abstract] [Full Text] [PDF]